Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lopalco

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
The Lancet. Rheumatology|March 29, 2026
Agentic AI in rheumatologyVincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone, et al.
Archives of Rheumatology|December 21, 2023
Beyond the horizon: Innovations and future directions in axial-spondyloarthritisVincenzo Venerito, Sergio Del Vescovo, Giuseppe Lopalco, et al.
Drugs in Context|May 19, 2025
Upadacitinib for the treatment of radiographic axial spondyloarthritis - case series and review of the literatureGiuseppe Lopalco, Arianna D'Antonio, Maria Sole Chimenti, et al.
International Journal of Molecular Sciences|April 13, 2023
Uncovering the Underworld of Axial SpondyloarthritisSergio Del Vescovo, Vincenzo Venerito, Claudia Iannone, et al.
Multiple Sclerosis and Related Disorders|May 15, 2020
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitisGiuseppe Lopalco, Sante Schiraldi, Vincenzo Venerito, et al.
Internal and Emergency Medicine|May 26, 2016
Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lensMarco Cattalini, Martina Soliani, Giuseppe Lopalco, et al.
Clinical Rheumatology|January 11, 2019
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritisVincenzo Venerito, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
Clinical Rheumatology|November 20, 2015
Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritisFlorenzo Iannone, Giuseppe Lopalco, Luca Cantarini, et al.
Expert Opinion on Biological Therapy|August 7, 2024
The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovationsGiuseppe Lopalco, Andrea Cito, Vincenzo Venerito, et al.
European Journal of Clinical Investigation|July 30, 2020
Predictors of long-term clinical remission in rheumatoid arthritisMarco Fornaro, Fabio Cacciapaglia, Giuseppe Lopalco, et al.
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
The Lancet. Rheumatology|March 29, 2026
Agentic AI in rheumatologyVincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone, et al.
Archives of Rheumatology|December 21, 2023
Beyond the horizon: Innovations and future directions in axial-spondyloarthritisVincenzo Venerito, Sergio Del Vescovo, Giuseppe Lopalco, et al.
Drugs in Context|May 19, 2025
Upadacitinib for the treatment of radiographic axial spondyloarthritis - case series and review of the literatureGiuseppe Lopalco, Arianna D'Antonio, Maria Sole Chimenti, et al.
International Journal of Molecular Sciences|April 13, 2023
Uncovering the Underworld of Axial SpondyloarthritisSergio Del Vescovo, Vincenzo Venerito, Claudia Iannone, et al.
Multiple Sclerosis and Related Disorders|May 15, 2020
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitisGiuseppe Lopalco, Sante Schiraldi, Vincenzo Venerito, et al.
Internal and Emergency Medicine|May 26, 2016
Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lensMarco Cattalini, Martina Soliani, Giuseppe Lopalco, et al.
Clinical Rheumatology|January 11, 2019
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritisVincenzo Venerito, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
Clinical Rheumatology|November 20, 2015
Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritisFlorenzo Iannone, Giuseppe Lopalco, Luca Cantarini, et al.
Expert Opinion on Biological Therapy|August 7, 2024
The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovationsGiuseppe Lopalco, Andrea Cito, Vincenzo Venerito, et al.
European Journal of Clinical Investigation|July 30, 2020
Predictors of long-term clinical remission in rheumatoid arthritisMarco Fornaro, Fabio Cacciapaglia, Giuseppe Lopalco, et al.
Pageof 23